NICOLE QUEEN: Open Payments
NPI 1073238846 · PARKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 24 payments from 8 companies in 2025. Trend: 2023 $77 · 2024 $228 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $134 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| ABBVIE INC. | 5 | $107 |
| Alkermes, Inc. | 3 | $62 |
| Indivior Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: INGREZZA, INVEGA SUSTENNA, VRAYLAR, SUBLOCADE, ARISTADA, SPRAVATO, Auvelity, HETLIOZ.
Industry payments across MD — which companies pay providers there.
